Skip to content
CompletedNot applicable

LSD-Perceptual-Choice-Study

NCT05976698 · LUCY · University Hospital, Basel, Switzerland

Closed to entry
Status
Not accepting participants
Not applicable
Phase
30
Target enrolment
1
Study sites
Outside the US

What it is testing

Summary

The aim of the study is to characterize the effects of low doses of LSD (d-lysergic acid diethylamide) on behavioral and neural indicators of feedback and feedforward signaling in perceptual decision-making.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Change in changepoint task

    Measured over three times (once on each of the three test days; interval between test days at least 7 days)

  • Change in history bias task

    Measured over three times (once on each of the three test days; interval between test days at least 7 days)

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 65 Years
Ages
All
Sex
Accepted
Healthy volunteers
Inclusion Criteria: * Willingness to adhere to the study protocol and sign the consent form * ≥ 18 and ≤ 65 years of age at Screening * Body mass index 18-29 * Fluent understanding of German * Normal or corrected-to-normal vision * Willingness to not operate a traffic vehicle or heavy machinery 24 hours after substance administration * Willingness to refrain from taking illicit psychoactive substances, including cannabis, for the duration of the study * Willingness to not consume more than one alcoholic standard drink the night before the study sessions and not consume alcohol for 24 h after each study session * Willingness to abstain from xanthine-based liquids from the evenings prior to the study sessions and during the sessions * Willingness to use effective birth-control throughout the study duration * Adequate task performance in the decision-making tasks during a practice session in the screening visit Exclusion Criteria: * Recent (\<30 days) or current participation in another clinical trial * Women that are pregnant, nursing, or planning to become pregnant during the study period * Current use of contraindicated/psychoactive medications or illicit drugs * Lifetime use of classical psychedelics more than 20 times, or any time within the previous two months * Consumption of \>5 cigarettes per day or \>20 alcoholic standard drinks per week * Severe chronic or acute medical condition * Hypertension (\>140/90 mmHg) or hypotension (\<85mmHg systolic) * Current or lifetime major mental health disorder * Personal or family (first-degree) history of a primary psychotic disorder

Where

1 study site

FacilityCityRegionCountry
University Psychiatric Clinics BaselBaselSwitzerland

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT05976698 on ClinicalTrials.gov →

Last updated in the registry 2026-05-29. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits